Patent Term Extension Application for LYNKUET (elinzanetant). Patent No. 7,683,056 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-1010

Patent Term Extension Application for LYNKUET (elinzanetant). Patent No. 7,683,056

Documents

Comments

Description

OPEN

Comment Period OpensFeb 2, 2026

Type	Title	Posted	Comments	Status
Other	Letter to U.S. Patent and Trademark Office	Apr 21, 2026	--

CDER

Patent Term Extension Application

Morrison & Foerster LLP

KaNDY Therapeutics Limited

LYNKUET (elinzanetant)

Patent No. 7,683,056

OPEN